Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases
ACS Medicinal Chemistry Letters · 10.04.2025 · 16 (4) · 560-566
DOI: 10.1021/acsmedchemlett.4c00599 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Medicinal Chemistry Letters, online erschienen am 22.03.2025. Verfasst von Alessia Onali und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria sp8, 09042 Monserrato, Cagliari, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A small library of novel thiazolidinone-based sulfonamide derivatives was designed, synthesized and evaluated for their ability to target human carbonic anhydrase (hCA) isoforms IX and XII, which are overexpressed in malignant cells and play a key role in metastasis and therapeutic response of cancer cells. A molecular hybridization approach was employed to design the molecules by combining different moieties identified as having antitumor activity. The thiazolidinone core was functionalized with benzenesulfonamide as a zinc-binding group and different isatin derivatives to enhance the chemical profile and optimize the hydrophilic/lipophilic balance. Biological evaluation against hCA I, II, IX and XII isoforms showed promising inhibitory activities, and some compounds exhibited selectivity and high inhibitory activity against hCA IX and hCA XII while not affecting off-target hCA I and hCA II. In particular, compound 3h demonstrated high selectivity with Ki values of 57.8 nM for hCA IX and 44.3 nM for hCA XII.
Autor:innen und Institutionen
- Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria sp8, 09042 Monserrato, Cagliari, Italy.
- Faculty of Pharmacy, University of Lubiana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.
- Dipartimento NEUROFARBA, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, 50019 Sesto Fiorentino, Florence, Italy.
ORCID-Profile: Alessia Onali, Erica Sanna, Antonio Lupia, Daniela Secci, Giulia Atzeni, Laura Demuru, Andrea Angeli, Filippo Cottiglia, Rita Meleddu, Roberta Emmolo, Angela Corona, Elias Maccioni, Claudiu T Supuran, Simona Distinto
Zitieren
APA
Onali, A., Sanna, E., Lupia, A., Secci, D., Atzeni, G., Demuru, L., Angeli, A., Cottiglia, F., Meleddu, R., Emmolo, R., Corona, A., Maccioni, E., Supuran, C. T., & Distinto, S. (2025). Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases. ACS Medicinal Chemistry Letters, 16(4), 560-566. https://doi.org/10.1021/acsmedchemlett.4c00599
Vancouver
Onali A, Sanna E, Lupia A, Secci D, Atzeni G, Demuru L, et al. Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases. ACS Medicinal Chemistry Letters. 2025;16(4):560-566. doi:10.1021/acsmedchemlett.4c00599
BibTeX
@article{Onali2025,
author = {Onali, Alessia and Sanna, Erica and Lupia, Antonio and Secci, Daniela and Atzeni, Giulia and Demuru, Laura and Angeli, Andrea and Cottiglia, Filippo and Meleddu, Rita and Emmolo, Roberta and Corona, Angela and Maccioni, Elias and Supuran, Claudiu T and Distinto, Simona},
title = {Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases},
journal = {ACS Medicinal Chemistry Letters},
year = {2025},
volume = {16},
number = {4},
pages = {560--566},
doi = {10.1021/acsmedchemlett.4c00599}
}
EUVIMED